Maropitant

From Self-sufficiency
Jump to: navigation, search
Maropitant
File:Maropitant.png
Systematic (IUPAC) name
(7R,8S)-N-[(5-tert-Butyl-2-methoxyphenyl)methyl]-7-[di(phenyl)methyl]-1-azabicyclo[2.2.2]octan-8-amine
Clinical data
Routes of
administration
Oral, subcutaneous
Legal status
Legal status
  • veterinary prescription only
Identifiers
ATCvet code QA04AD90 (WHO)
PubChem CID 23724948
Chemical data
Formula C32H40N2O
Molar mass 468.67 g/mol[[Script error: No such module "String".]]
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Maropitant (Cerenia (US)), used as maropitant citrate (USAN), is a neurokinin (NK1) receptor antagonist, which was developed by Pfizer Animal Health specifically for the treatment of motion sickness and vomiting in dogs. It has not been approved by the FDA for use in any animal except dogs.[citation needed] It was approved for use on February 2007.

See also

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />


it:Maropitant